AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitlomera M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Mednich Pharmaceuticals

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitlomera M 50mg/500mg Tablet

Diabex Duo 50mg/500mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like vision impairment and kidney disease, and may lower the risk of stroke or heart attack. Diabex Duo 50mg/500mg may be used independently or in conjunction with other anti-diabetic treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and current medications. Consuming the tablets with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under medical supervision. Adherence to your prescribed diet and exercise plan is crucial for successful diabetes management; lifestyle choices significantly influence blood sugar control. Common side effects include nausea, diarrhea, vomiting, abdominal discomfort, headache, and throat irritation. Low blood sugar (hypoglycemia) is a potential side effect, especially when used with insulin or sulfonylureas; learn to identify and manage this complication. This medication isn't suitable for everyone. Inform your physician of any pre-existing kidney, liver, heart, or pancreatic conditions, or excessive alcohol consumption before starting treatment. Pregnant or lactating women should consult their doctor. Interactions with other medications are possible; disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its potential to decrease blood glucose. Your doctor will monitor kidney function and blood sugar levels throughout your treatment.

Primary Ingredients of Sitlomera M 50mg/500mg Tablet

There is no text provided to rephrase.

Uses of Sitlomera M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitlomera M 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Sitlomera M 50mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with food.

Common Side effects of Sitlomera M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitlomera M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sitlomera M 50mg/500mg Tablet with a meal.

How Sitlomera M 50mg/500mg Tablet works:

Sitagliptin/metformin 50mg/500mg tablets (Sitlomera M) combine two agents to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action facilitates superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Sitlomera M 50mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitlomera M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitlomera M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitlomera M 50mg/500mg Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Sitlomera M 50mg/500mg Tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

The use of Sitlomera M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Sitlomera M 50mg/500mg Tablet :

Should you forget a dose of Sitlomera M 50mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitlomera M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitlomera M 50mg/500mg Tablet

Sitlomera M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Sitlomera M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. Preventive measures suggested by some researchers include annual supplemental vitamin B12 intake.
Sitlomera M 50mg/500mg Tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Sitlomera M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitlomera M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitagliptin + Metformin (like Sitlomera M 50mg/500mg) can rarely cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This risk is increased in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin + Metformin and seek immediate medical attention.
Sitlomera M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitlomera M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitlomera M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitlomera M 50mg/500mg tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin + Metformin (Sitlomera M 50mg/500mg) can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitlomera M and seek immediate medical attention.
Prolonged use of Sitlomera M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, neurological issues such as numbness, tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitlomera M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitlomera M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitlomera M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Consuming alcohol with Sitlomera M 50mg/500mg tablets is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitlomera 50mg/500mg) can cause lactic acidosis, a serious, potentially fatal buildup of lactic acid in the blood (also known as MALA – Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney problems, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitlomera M 50mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, supplemental vitamin B12 is recommended at least annually.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Sitlomera M 50mg/500mg Ta...
324